Repligen
RGEN
#2598
Rank
NZ$11.60 B
Marketcap
NZ$205.73
Share price
0.27%
Change (1 day)
2.66%
Change (1 year)
Categories

Repligen (RGEN) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : NZ$1.44 Billion

According to Repligen 's latest financial reports the company's total liabilities are NZ$1.44 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Repligen - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$1.45 B-4.14%
2024-12-31NZ$1.51 B10.92%
2023-12-31NZ$1.36 B40.08%
2022-12-31NZ$0.97 B9.81%
2021-12-31NZ$0.89 B71.93%
2020-12-31NZ$0.51 B2.5%
2019-12-31NZ$0.50 B113.12%
2018-12-31NZ$0.23 B10.81%
2017-12-31NZ$0.21 B23.37%
2016-12-31NZ$0.17 B405.4%
2015-12-31NZ$34.31 M62.37%
2014-12-31NZ$21.13 M17.69%
2013-12-31NZ$17.95 M14.66%
2012-12-31NZ$15.66 M
2011-03-31NZ$6.84 M-8.58%
2010-03-31NZ$7.48 M-8.33%
2009-03-31NZ$8.16 M38.75%
2008-03-31NZ$5.88 M19.08%
2007-03-31NZ$4.94 M-5.5%
2006-03-31NZ$5.23 M12.18%
2005-03-31NZ$4.66 M27.01%
2004-03-31NZ$3.67 M-9.38%
2003-03-31NZ$4.05 M-33.04%
2002-03-31NZ$6.05 M91.2%
2001-03-31NZ$3.16 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
NZ$207.93 B 14,289.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$97.31 B 6,634.12%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$190.60 B 13,090.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$122.53 B 8,379.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$0.14 B-90.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$2.23 B 54.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$2.36 B 63.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.87 B-39.34%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.58 B 78.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
NZ$6.72 B 365.19%๐Ÿ‡บ๐Ÿ‡ธ USA